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Interoduction 
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INTRODUCTION 
“The delivery of the infant into the arms of a conscious and pain 
free mother is one of the most existing and rewarding moments in 
medicine” - Moir 
   It’s never the fear of bringing a new life in to the world that 
frightens a woman. It is the fear of the pain she has to endure to do it. 
From all the happiness mankind can gain is not in pleasure but 
in rest from pain – John Dryden 
Melzak
29
 et al 1981 – presented evidence that the labour pain is 
the most severe that have ever assessed. 
Labour pain is considered to be one of the most intense and 
stressful experiences (Sheiner
39
 et al 2000) especially for nulliparous 
woman. Although studies have found a significant rise in pain 
threshold during labour (Ohel et al 2007) it is an important goal to 
provide safe and effective methods of analgesia for woman in pain in 
order to obtain her maximum cooperation. (O’ Hana et al 2008).  
Most women in the first stage of labour feel pain predominantly 
in the lower abdomen, whereas other experience severe low back 
pain, in approximately 30% of cases the pain is continuous and 
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annoying known as back labour (Phiangjit and Wiruchpongsanon  
2006) 
The uterine cervix and corpus are supplied by afferent neurons 
ending in the dorsal horns of spinal segments (T10 – L1). Since the 
cutaneous afferents from lower back converge to the dorsal horns in 
the same segment, there is anatomical support for the assumption that 
low back pain in labour is referred pain (Wiruchpongsanon
47
 2006) 
Based on gate control theory or counter irritation theory, 
various attempts have been made to relieve labour pain by treating 
dermatomes having the same cutaneous innervations with methods 
such as transcutaneous electric Nerve Stimulation, Intracutaneous 
Sterile Water Injections and acupuncture with varying results. 
Pharmacological methods used to relieve labour pain like 
narcotics are not always warranted because of their maternal side 
effects such as drowsiness and loss of control and potential neonatal 
respiratory depression. (Shohreh Bahasadri
2
 et al 2006) 
While Epidural analgesia has become the gold standard for 
diminishing pain of labour and birth, it is associated with an increase 
in pyrexia during labour and possibility of long term backache and 
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neurological symptoms, also can cause sufficient motor block to 
adversely affect the mobility of the laboring woman and most lose the 
reflex desire to push. (Reynolds
38
 1994). It also had an impact on 
breast feeding leading to lactational failure. 
Epidural analgesia, Nitrous Oxide and Pudendal block which 
are widely used are not always available in all centers and beside that 
none of these methods have proven to be effective in reducing low 
back labour pain. Therefore an effective, inexpensive and simple 
method with no serious side effect for reducing low back pain in 
labour would be very useful. (Shoreh Bahasadri
2 
et al 2006). 
Intracutaneous injection of sterile water in the skin over the 
sacrum have been shown to relieve the pain of labour without 
concerns that the method might harm the mother and / or fetus or 
slow the labour pattern. (Lena Martensson
27 
et al 2008). 
This technique could of particular use in hospitals that don’t 
have access to epidural analgesia and it could be also be helpful for 
women who want to avoid medications during labour and birth. 
(Reynolds
38
 1994). 
 
Aim of Study 
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AIM OF THE STUDY 
 
1. To determine the effectiveness of intracutaneous injection 
of sterile water over sacrum in relieving low back pain 
during labour.  
2. The aim of the study was to carry out a randomized 
control trial, including a placebo treated patient group 
with normal saline and comparing with sterile water 
injections treated patient group.  
3. To assess parturient satisfaction with sterile water 
analgesia with a follow up questionnaire on the first post 
partum day. 
 
 
 
 
History of Obstetric 
analgesia with Sterile 
Water Injection 
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HISTORY OF OBSTETRIC ANALGESIA 
Pain relief in labour has always been surrounded with myths 
and controversies. Hence providing effective and safe analgesia 
during labour has remained an ongoing challenge. 
Historically, the era of obstetric anesthesia began with James 
Young Simpson, when he administered Ether to a woman with a 
deformed pelvis during childbirth. His concept of etherization of 
labour was strongly condemned by critics. The religious debate over 
the appropriateness of anesthesia for labour continued till 1853, when 
John Snow administered Chloroform to Britain’s Queen Victoria 
during birth of her eighth child, Prince Leopold. 
History of sterile water injection 
This technique is not new and has been mentioned in the 
literature by Halsted when he wrote – The skin can be completely 
anesthetized to any extent by cutaneous injection of water. Dr.Samuel 
Gant used it in connection with fistula and polyp surgery. 
The method began to be used in the obstetric field in the late 
1920. Sterile water injections have been used for pain other than 
labour pain with positive outcomes including acute attack of 
urolithiasis and for neck and shoulder pain after whiplash injury. 
Pain Pathway 
PAIN IN LABOUR : PATHWAYS AND MECHANISMS 
 
 
Major pathways of labour pain 
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PAIN PATHWAY 
Pain in the first stage of labour is generated largely from uterus 
and is visceral in nature. Sympathetic visceral afferents transmit 
sensation of pain from the uterus, cervix and upper vagina through the 
Frakenhauser ganglion, the pelvic plexus, and the middle and superior 
internal iliac plexus in to the spinal cord through white rami 
communicantes associated with T10, T11, T12 and L1. Early in the 
first stage of labour, pain of uterine contractions is transmitted 
predominantly through eleventh and twelfth thoracic nerves. 
Pain with vaginal delivery is somatic pain arising from stimuli 
from the lower genital tract. These are transmitted primarily through 
the pudendal nerve (S2,3,4) which provides sensory innervations to 
the perineum, anus and more medial parts of the vulva and clitoris. 
Opinions regarding pain relief during labour invite divergent 
and widely polarized views. There are protagonists of the “laissez 
faire” policy of leaving things to nature but the distress felt by 
laboring women is so intense that there is a definite role for labour 
analgesia. 
 
Role of Pain Relief and 
Theories of Pain 
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ROLE OF PAIN RELIEF 
Labour pains may be aggravated by anxiety, fear, maternal 
expectations and the mother’s state of preparation for delivery. As 
with other forms of visceral pain labour pain stimulates an intense and 
complex autonomic response, it increases maternal oxygen 
consumption, cardiac output and circulating catecholamines 
(Schnider
39 
 et al 1983). The rise in serum catecholamines may cause 
fetal tachycardia or bradycardia and dysfunctional uterine 
contractions. Freedom from pain improves the environment for both 
mother and fetus and thereby improves obstetric outcome. 
For the mother, obstetric analgesia provides relief from pain 
controls alterations in circulation, ventilation and undue muscular 
efforts. It ensures better patient co operation.  
For the fetus, labour analgesia means shorter and less traumatic 
labour, protection against hypoxia and fetal respiratory depression at 
birth, and protection against needless instrumental assisted delivery 
necessitated by maternal distress. 
To the obstetrician, it provides a better control of events 
emerging in course of labour, reduces pressure from the patients and 
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relatives to intervene and ensures optimum condition to prevail at the 
time of childbirth. 
It is possible that pain reduction in the active phase of labour is 
associated with increased parasympathetic tone, which improves 
labour, resulting in descent of the fetus and improving the likelihood 
of vaginal delivery. Enhanced relaxation accompanying pain relief 
experienced with the sterile water injection promotes rotation of fetal 
occiput to a position favourable to vaginal delivery. 
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THEORIES OF PAIN 
Specificity theory 
Pain and touch sensors on the skin are viewed  to a specific pain 
centre in the brain. This theory is biological and does not account for 
any psychological factors in the pain experience. Pain receptors carry 
the painful sensation directly to the brain, and any emotions displayed 
as part of pain when there is no organic basis for the pain.   
Sensory Decision Theory 
This theory relies heavily on the psychological perception of a 
painful stimulus. Painful stimuli is perceived according to the 
individuals cognitive processes eg., perceptual habits, beliefs, 
expectations, costs and rewards and memory of previous pain 
experiences. Therefore this theory espouses that individual 
characteristics and situational factors affect pain. It allows for the 
need to focus on the painful area in order to become aware of the pain 
signals. 
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PAIN GATE by Melzack and Wall 
 
 
Conditions that open or close the gate 
 Conditions that open the 
gate 
Conditions that close the 
gate 
Physical conditions Extent of the injury Medication 
 Inappropriate activity level Counter stimulation, eg. 
Massage 
Emotional conditions Anxiety or worry Positive emotions 
 Tension Relaxation 
 Depression Rest 
Mental conditions Focusing on the pain Intense concentration or 
distraction 
 Boredom Involvement and interest in 
life activities 
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Pattern theories 
Pain conducting nerves are shared with other sensory nerves – 
pattern of activity from the nerve cells dictates how the pattern is 
interpreted. 
Gate control theory 
Proposed by Melzack
27 
and Wall in the 1960’s. Gate opened or 
closed by 3 factors (Banyard p160) 
1. Activity in the pain fibres – opens the gate 
2. Activity in other sensory nerves – closes the gate 
3. Messages from the brain – concentrating on the pain or trying not to 
think about it. 
Painful impulses from the pain receptors only reach the brain if 
the “Gate” is open. 
Three variables control this gate 
1. A - Delta fibres ( Sharp Pain ) 
2. C - fibres ( Dull pain ) 
3. A - beta fibres that carry messages of light touch 
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Special neurons located in the grey matter of the spinal cord 
make up the gate. This gate has the ability to block the signals from 
the a–delta and c– fibres preventing them from reaching the brain. 
The special neurons in the spinal cord are inhibitory i.e, they 
keep the gate closed. These special neurons make a pain blocking 
agent called enkephalin. This is an opiate substance similar to heroin 
which can block Substance P the neurotransmitter from the C fibres 
and the A- delta fibres and this keeps the gate closed. 
C- fibres and A- Delta fibres obstruct (inhibitory) the special 
gate neurons and tend to open the gate. A-beta fibres are irritable 
(excitatory) to the special gate neurons and tend to keep the gate 
closed. 
If impulses in the C and A – Delta Fibres are stronger than the 
A- beta fibres the gate opens. A-delta fibres are always stronger. 
Specialized nerve impulses arise in the brain itself and travel 
down the spinal cord to influence the gate. This is called the central 
control trigger and it can send both obstructive and irritable messages 
to the gate sensitizing it to either C or a – beta fibres. 
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Eg. If the central control sensitizes the gate to C fibres (dull 
pain) it is more likely to open. If it sensitizes to A- Beta fibres (light 
touch) it is more likely to close. 
Hence cognitive processors influence the transmission of pain. 
Cognitive processors that open the gate: 
Anxiety, tension, depression eg persons having surgery and 
focusing on pain 
Cognitive processors that close the gate 
Happiness, Optimism, Distraction and Concentration eg. 
soldiers. 
In summary whether or not pain impulses are received by the 
brain is dependent on a combination of the following 
1. The strength of the C fibre impulses ( opening the gate ) 
2. The strength of the A- beta fibre impulses ( closing the gate ) 
3. The central control trigger’s sensitization of the gate to C or A- beta 
Fibres (to either open or close the gate) eg. Rubbing area after a bump 
reduces the pain by stimulating the A-beta fibres of light tough to 
close the gate. Theoretically, Gate control theory is the most 
comprehensive and widely accepted theory at present. 
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Descending pain relief system 
A painful stimulus activates the central pain inhibitory system’s 
production of endogenous opioids. Sensory signals from the painful 
area pass ascending pathways to the brain. These signals stimulate 
areas such as the peri-acqueductal grey matter to produce β- 
endorphin and neurotensin and stimulate the great raphe nucleus to 
produce noradrenaline and serotonin. These substances proceed 
through descending pathways back to the dorsal horn and inhibit the 
nociceptive transmission at the spinal level. 
Diffuse Noxious Inhibitory Control 
Diffuse Noxious Inhibitory Control (DNIC) is another 
mechanism, ie. A physiological system based on the concept that pain 
can be controlled by stimulation at points distal to its source. The idea 
is to apply a painful stimulus elsewhere than the area to which the 
initial pain is projected, thus achieving a pain relief effect. The 
endorphin system is involved and it is not necessary to administer 
pain stimuli in the affected area since of the effect is general 
according to this explanatory model. 
 
Methods for Pain Relief 
in Labour 
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METHODS FOR PAIN RELIEF 
Since time immemorial there have been attempts to reduce the 
suffering of the laboring woman and from this has evolved several 
methods of alleviating pain during labour. 
Non pharmacological methods 
1. Hypnosis has been used periodically since Anton Mesmer first wrote 
about it in 1977. It produced effective analgesia in only 25% of 
mothers by producing a deep trans. 
2. Relaxation / breathing techniques / Massage 
These form of pain relief can allay anxiety, encourage 
relaxation, provide a focus of distraction from pain and tension and 
encourages a positive attitude. 
3. Positioning and movement 
Mobility and the adoption of a position of comfort will be 
advantageous to the woman. An upright or kneeling position is said to 
improve the dimension of pelvis and encourage forward rotation of 
the fetus. This may lead to a decrease in the use of regional 
anaesthesia and analgesics. 
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4. Intradermal injection of sterile water 
Provides relief of pain and backache by injecting intradermally 
sterile water of 0.1 – 0.5 cc at 4 sites in the lower sacral region. 
5. Temperature modulation 
Hot or cold pack, hot or cold water. 
Hot packs to the abdomen and back or the perineum in the 
second stage of labour have the potential to relieve the burning 
sensation of pain. For some women the use of extreme cold may be 
similarly useful. 
6. Transcutaneous electrical nerve stimulation 
It is thought to work by interrupting pain transmission along the 
sensory pathway and by stimulating endogenous opioids. 
Commonly two electrodes are applied vertically over the 
woman’s back parallel to her spine between the areas of T 10 down to 
S4. 
The electric current used may be of low frequency and 
intermittent or high frequency and continuous. 
Low frequency TENS stimulate the release of endogenous 
opioids while the high frequency current closes the pain gate- the 
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sensation experienced may be felt as a tingling or as a sharper electric 
shock sensation. 
7. Acupuncture  
A form of Eastern medicine said to relate to the flow of energy 
called Qi within the body where needles are inserted along specific 
pathways or meridians. 
In action may be related to release of endogenous opioids. 
8. Herbalism and Aromatherapy 
These make use of natural plant extracts or essential oils. These 
remedies may improve physiological balance, strength and stamina 
within the mind and body. Knowledge of specific usage is important 
as the use of some of these remedies is contraindicated in pregnancy 
and labour, while others may have an adverse effect on the baby if it 
comes in direct contact with them. 
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PHARMACOLOGICAL METHODS FOR PAIN RELIEF 
DURING LABOUR 
Systemic Analgesia 
Parenteral administration of opioids and sedative hypnotics are 
a commonly used method of analgesia. Opioid receptors located in 
cardiac atria are activated by circulating opioids to excite vagal 
afferents. These in turn activate descending nerve fibres that are 
inhibitory to pain stimuli. Thus decreasing the sensation of noxious 
stimuli. In effect intravenous opioids produce spinal analgesia without 
spinal injection. 
Intravenous patient controlled analgesia 
The use of an intravenous PCA may be of use for women where 
the placement of an epidural is contraindicated. The total drug 
requirement to achieve adequate pain relief is usually less using this 
method than with intra muscular narcotics or a continuous 
intravenous infusion. Fentanyl (10µg/ml ) is the drug of choice. 
Inhalation Analgesia 
ENTONOX (50 : 50 mixture of O₂ and  N₂O) is used. This is a 
colourless, odourless gas. Used in higher concentration it can provide 
effective pain relief with the advantage that its effects are short lived 
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and there is minimal complication in the neonate. It is obtained by the 
woman’s own respiratory effort via a piped supply. The Obstetric 
Association UK ( 2005 ) guidelines state that Entonox is being phased 
out from UK in view of poor analgesic efficacy and environmental 
pollution. 
Analgesia is obtained within 20 – 30 seconds of commencement 
and maximum effort is felt after about 45 seconds. Self administration 
is the recommended method of use as the patient drops the mask or 
mouth piece if she absorbs too much of the gas. 
Epidural analgesia 
Epidural analgesia can provide an effective form of pain relief 
in labour. It may be beneficial for women having a long or painful 
labour, be required on the grounds of fetal benefit or administered for 
maternal or obstetric indications. It may also be provided at maternal 
request. 
Complications include increased frequency of instrumental 
delivery, some degree of motor weakness, dural puncture, vascular 
placement, hypotension and insufficient block. Epidural analgesia 
prolongs duration of labour.  
Review of Literature 
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REVIEW OF LITERATURE 
 On review of literature several studies have consistently shown 
that sterile water injections provide good pain relief particularly for 
back pain during labour. 
1. Saxena Kirti N
15 
 et al in Indian Journal of Anesthesia 
(April 2009) reported that, sterile water given 
intracutaneously seems to be an efficient and simple method 
for antagonizing parturition  low back pain.  
2. M.Kasperink EK Hutton
13
 et al (2009) in BJOG, 
evaluated caesarean section rates among women who 
received sterile water injection in labour with other form of 
treatment and concluded, Caesarean section rate was 4.6% in 
the sterile water injection group and 9.9% in the control 
group.  
3. Vikki Fogarty
45
 et al (2008) Women and Birth, concluded 
that intradermal injection of sterile water possesses powerful 
analgesic benefits for women experiencing low back pain in 
labour and their use in therapeutic setting is justifiable. 
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4. Bahasadri
2 
 et al (2006) ANZJOG, stated that  the efficacy 
of SubCutaneous sterile water injection in reduction of 
labour pain compared with placebo.  The median pain score 
in the sterile water group was significantly lower than the 
placebo group at 10 min, as well as 45 min after the 
injection. 
5. Wiruchpongsanon
47
 (2006) Journal of the Medical 
Association of Thailand, studied the effectiveness of 
Intracutaneous injection of sterile water in relieving low 
back pain during labor in Thai women.  Mean pain reduction 
was significantly greater in the treatment group compared to 
the placebo group at 30 min, 1 and 2 hours after injection (p 
< .001). 
6. Martensson
27
 et al (2006) Survey in Sweden Birth 
investigated, whether during injections of sterile water, there 
is any difference in perceived pain between IntraCutaneous 
and SubCutaneous injections.  IntraCutaneous injections of 
sterile water showed to be significantly more painful than 
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SubCutaneous injections even when trial, day and injection 
location were taken into consideration (p < 0.001) 
7. Peart K, James W and Deocampo
35,36
 J 2006. Birth 
Issues. Reported the Use of sterile water injections to relieve 
back pain in labour to be very effective.  
8. Martensson and Wallin
28
  (1999) BJOG, evaluated that the 
relief of pain in labor with SubCutaneous and intracutaneous 
injections of sterile water vs placebo.  The pain reduction 
was significantly greater in both treatment groups compared 
to placebo at 10 and 45 min after treatment. 
9. Labrecque
17
 et al (1999) Journal of family Medicine 
Practice,  compared with sterile water injections and TENS 
for low back pain during labor.  Sterile water injections are 
more effective than standard care and TENS for low back 
pain. 
10. Dahl and Aarnes
8
 (1991) Tidsskr Nor Laegeforen, 
evaluated  the method and factors possibly influencing the 
efficacy of  Sterile water papules and found to have better 
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relief for labor pain in the IntraCutaneous group compared 
with the dry needle group early treatment yielded best effect. 
11. Trolle
44
 et al (1991) American Journal of Obstetric 
Gynecology,   evaluated the analgesic effect of intradermal 
sterile water block for back pain during labor.  Significantly 
greater reduction of VAS score in the sterile water group 
compared with the normal saline group, up to 90 min after 
treatment. 
12. Ader
1
 et al (1990) Pain Journal, investigated the efficacy 
of sterile water papules for back pain during labor. 
Significantly greater reduction of VAS score in the sterile 
water group compared with the normal saline group :  
analgesic effect up to 90 minutes. 
13. Lytzen
26
 et al (1989) Acta Obstet Gynecol Scand,  
evaluated that if sterile water papules can be an altenative for 
alleviating back pain.  VAS score reduced significantly a 
hour after injection compared with just before 
administration. 
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14. Trolle
44
 et al (1986) Ugeskr Laeger (Danish Journal), 
evaluated if back pain during labor can be treated with 
IntraCutaneous sterile water papules.  The treatment group 
experienced significantly better pain relief compared with 
the control group, up to 60 and 120 min after treatment. It 
was also noted that there were fewer caesarean sections in 
the intracutaneous sterile water group. 
Mode of action of sterile water injection 
Bonica states that, Uterine contractions are felt as back pain 
became rami of T10 – L1 supplying the uterus also supply the skin 
over the lumbo-sacral area. The cutaneous branches of the lumbar and 
lower thoracic nerves cover a considerable caudal area. They transmit 
referred pain from uterus to a skin area over the vertebrae L3 – 
S2.The injections were given adjacent to the Michaelis’ rhomboid 
because this is the area where referred pain from the uterine 
contractions were felt. 
 Injecting solutions of Osmolality other than blood irritates 
biological tissues. Sterile water evokes intense pain, probably due to 
difference in osmolality. Irritation of skin during administration of 
 25
sterile water stimulates the gate control effect and thereby the 
endogenous opioid system.  
 In the clinically, controlled double blind study by Bengtsson
4
 et 
al acute ureteric colic was treated by injecting four papules of sterile 
water over cutaneous area where projected pain from the kidney and 
the upper urinary tract was felt.  
 Because sterile water is hypo-osmolar, it probably irritates the 
nerve endings leading to brief pain initially which is followed by 
analgesia, while saline being isoosmolar with blood does not irritate 
the nerves at all and therefore does not lead to analgesia.  
 The analgesia mechanism of action was provided by gate 
control theory or counter irritation theory.  
Interruption of the pathway of pain is the desired action of 
sterile water injections with Trolle
44
 et al,  first suggesting the area of 
Michaelis Rhomboid as the recommended site for injections because, 
subjectively, this is the area where the pain is felt  acutely by 
labouring women. When the sterile water is injected under the skin it 
raises a small bleb or "papule" which causes local irritation and a 
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strong sensory stimulation of the surrounding skin nociceptors for 
about 30 s. A-hyperaemic zone is observed around the bleb for some 
hours after demonstrating a prolonged irritation of the cutis. The 
analgesia induced by this stimulation may be caused by gate control 
at the spinal level and seems to be an important factor for the 
treatment to be effective, but this area provokes conjecture in the 
literature. Bahasadri
2 
et al concurs that the gate control theory may 
provide an explanation for the mode of action of sterile water 
injections but because the inhibition of pain is not restricted to one 
specific segment, he suggests that there must be a more nonspecific 
modulation of pain. Ader
1
 et al. speculates that the analgesic effect is 
similar to the stimulation of endogenous opioids seen with the use of 
acupuncture or TENS in labour and may act as "a long lasting 
segmental acupuncture". The Danish perspective from Trolle
44 
et al.  
tells us that hyperstimulation of a skin area can affect perception of 
visceral pain and it appears that "the mechanism of referred pain 
can be reversed to produce referred analgesia" . 
Counter irritation was described by Melzack
29 
as the 
phenomenon of one painful stimulus reducing the pain caused by 
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another noxious stimulus and may explain the pain-reducing effect of 
both sterile water injections and acupuncture. The Swedish and later 
Iranian studies  discussed the concept of diffuse noxious inhibitory 
control (DNIC) which is a physiological mechanism produced to 
explain the effects of counter irritation. DNIC is the inhibition of 
multireceptive neurons in the dorsal horn of the spinal cord, when a 
noxious stimulus is applied to a region of the body remote from the 
neurone's excitatory receptive field" This ultimately means that pain 
is reduced in areas remote from those where stimuli are present, thus 
supporting the use of sterile water injections during labour.
Materials and Methods 
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MATERIALS AND METHODS 
This study was conducted after approval of the Institutional 
Ethical Committee at Government Rajaji Hospital, Madurai, attached 
to Madurai Medical College,  from Jan 2010 to June 2010. 
 Under this study 200 consecutive patients who were admitted 
in clean labour theater and in active labour were enrolled for the 
study. Out of which 100 patients received the sterile water injection 
served as study group. The other 100 patients received the normal 
saline injection served as the control group. 
In both study group and control group  
50 patients were primigravidae 
50 patients were multigravidae 
The study group and control group was well matched in age, 
parity and labour characteristics. 
Informed consent was obtained from parturient of both study 
and control groups. 
Inclusion criteria : 
The following criteria were applied prior to including the cases 
in the study. 
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1. Pregnant women with gestational age (37 – 41 weeks) 
2. Age of the patient 18 – 30 years 
3. Patient not receiving any analgesics prior to onset of labour 
4. Single foetus with vertex presentation 
5. Patient at the onset of active phase of labour with a cervical 
dilatation of 2-3 cms complaining of low back pain 
6. No evidence of cephalo – pelvic disproportion 
EXCLUSION CRITERIA 
1. Patient not willing for the procedure 
2. Patient with contraindication for spontaneous vaginal delivery 
• Fetal distress 
• CPD 
• Malpresentation  
• Placenta praevia 
• Macrosomic baby  
3. Medical disorders associated with pregnancy 
• Diabetes  
• Hypertension  
• Neurological diseases 
 30
• Blood dyscrasias 
4. Infection in the area of injection 
5. Any observable spine lesions 
6. Suspicious or presence of dermatological pathology interfering 
with injection 
7. Patient in latent phase of cervical dilatation – more than 5 cms 
8. Patient received analgesics less than 3 hours prior to injection. 
 
Cases were selected after detailed history was taken. A thorough 
general and obstetric examination was done. Vital parameters were 
recorded. Basic investigations which included, urine examination for 
albumin, sugar., blood hemoglobin estimation, blood grouping and Rh 
typing were done. Ultrasound abdomen was performed to rule out any 
fetal abnormality to detect placental site, gestational age and amniotic 
fluid volume. Pelvic assessment to rule out CPD was performed. Patients 
with borderline and definite CPD were excluded from the study. 
Informed consent was obtained. 
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The following parameters were monitored 
1. Progress of labour with partogram 
2. Maternal well being 
3. Fetal well being 
Participants who fulfill the selection criteria were subjected for active 
management of labour in the form of  
1. Nutrition in the form of liquids 
2. Intravenous access in the form of IV canula 
3. Prophylactic antibiotics after rupture membranes. 
4. Subsequent observation and examination included. 
• Maternal vital data every 1-2 hours.  
• Uterine contractions – frequency and duration 
• The aim is to produce cervical dilatation of atleast 1 cm per hour. 
• In case of hypotonic uterine contractions, oxytocin drip was started, at 
the rate of 2 mU/minute and increased gradually till achieving uterine 
contractions lasting for 45 – 60 seconds and recurring every 3 minutes 
with a maximum infusion rate of 20 – 30 mU/minute. 
• Fetal heart rate every 30 minutes to detect fetal distress. 
  
PALPATION OF ANATOMICAL LAND MARKS 
 
 
 
 
 
MARKING THE ANATOMICAL LANDMARKS 
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• Rate of cervical dilatation and head descent was assessed every hour 
by vaginal examination and the data was  recorded in the partogram. 
The women were randomized in to 2 groups 
GROUP A – STERILE WATER INJECTION GROUP 
GROUP B – NORMAL SALINE INJECTION GROUP 
Materials  
Materials needed are sterile water ampoules, normal saline 
ampoules, insulin syringe, alcohol skin wipes and Universal Pain 
Assessment VAS Scale. 
Method of administration 
Procedure  
1. Patient position – sitting position. 
2. Anatomical points located as follows 
Point 1 - The posterior superior iliac spines (Dimple of Venus), 
palpated by feeling the bony prominences just lateral to the sacrum 
and below the iliac crest. 
Point 2 – 3 cms below and 1 cm medial to point 1. 
Point 1 and 2 on both sides form an area being referred as Michaelis’ 
rhomboid
15. 
 INJECTING 0.5cc WITH INSULING SYRINGE 
 
 
 
 
 
FORMATION OF BLEB AFTER INJECTION 
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3. Skin was cleansed with alcohol wipes 
4. Group A received 4 intracutaneous injections of 0.5 cc sterile water at 
the already marked 4 points in sitting position.  These injections were 
administered with 1 ml insulin syringe with fine 30 gauge needle, 
during the peak of uterine contraction to mask any administration 
pain. 
5. Group B  received 4 intracutaneous injections of normal saline in the 
same region.  
All the patients had a brief stinging pain when the injection was 
given. The stinging pain lasted longer in the sterile water group but 
subsided within few seconds.  
Assessment of pain relief was performed using a visual 
analogue scale (VAS), before injection, at 10 minutes, 45 minutes and 
90 minutes of post administration. 
 The acceptability of the technique by the patient was assessed in 
the first post partum day by a questionnaire, stating whether the 
patient will accept this technique in her future labour or not. 
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RESULTS  
Observation and Analysis of the Study 
 This study was conducted on 200 antenatal women out of which 100 
patients were given sterile water injection at the onset of active labour, 
who served as the study group. 
 The remaining 100 women who served as controls were given 
normal saline injection.  
Characteristics of the cases studied  
I. AGE 
Distribution of cases according to age group. 
Age Group Group A          ( Sterile 
water) 
Group B 
(normal saline) 
No. % No. % 
15-20 16 16% 9 9% 
21-25 58 58% 52 52% 
26-30 26 26% 39 39% 
 100 100 100 100 
Mean 23.80 24.39 
SD 3.06 3.09 
P = 0.177    Not significant 
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On analysis of study group age wise, 16% of cases were in the age 
group of 15 – 20. 58% of cases were in the age group of 21 – 25. 26% of 
cases were in the age group of 26 – 30. The mean age of study group was 
23.8 years. In control group, 9% cases were in the age group of 15 -20, 
52% cases were in the age group of 21 – 25, 39% cases were in the age 
group of 26 – 30. The mean age of control group was 24.39 years. There 
was no statistical significance in age of both groups  ( P=0.177). 
40
50
60
70
70
66
34
N
O
.
O
F
 
C
A
S
E
S
BOOKING STATUS
0
10
20
30
Study Control
30
N
O
.
O
F
 
C
A
S
E
S
Booked Unbooked
 36
 
2. Booking status:  
 Group A           
( Sterile water) 
Group B 
(normal saline) 
No. % No. % 
  Booked
  
70 70 66 66 
Unbooked 30 30 34 34 
 
P =  0.086  (Not significant) 
 In study group, 70% of the cases were booked, 30% of the cases 
were unbooked. In control group, 66% of the cases were booked, 34% of 
the cases were unbooked.  
The P value of 0.086 was insignificant. 
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3) Distribution of cases according to residence  
 Group A                      
( Sterile water) 
Group B 
(normal saline) 
No. % No. % 
Rural 68 68 64 64 
Urban 32 32 36 36 
 
P =  0.551  (Not significant) 
 In study group 68% of cases were from rural areas and 32% of cases 
from urban areas. In control group 64% of cases were from rural areas and 
36% of cases from urban areas. 
The P value 0.551  was insignificant. 
 38
 
4) Gestational age wise distribution 
 In both study and control group only term patients with  gestational  
age ranging from 37-41 weeks were selected.  
5) Distribution of parity:  
 Group A                      
(Sterile water) 
Group B 
(normal saline) 
No. % No. % 
Primigravida  50 50 50 50 
Multigravida  50 50 50 50 
Total  100 100 
P =  1.005  (Not significant) 
 
In both the study and  control group parity was equally distributed  
 50%  cases were primigravidae  
 50%  cases were multigravidae 
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6) Membrane Status  
  Group A                      
(Sterile water) 
Group B 
(normal saline) 
 No. % No. % 
Intact  88 88 85 85 
absent 12 12 15 15 
 
P =  1.007  (not significant) 
In study group 88% cases had intact membranes and in 12% of cases 
membranes were absent. In control group 85% cases had intact membranes 
and in 15% of cases membranes were absent. 
The P value 1.007 was insignificant. 
 
7.62
4.34 4.4
4.06
7.68
5.74
7.4
7.6
0
1
2
3
4
5
6
7
8
9
VAS at O Min. VAS at 10 Min VAS at 45 Min VAS at 90 Min
N
O
.
O
F
 
C
A
S
E
S
MEAN VAS SCORES - PRIMI GRAVIDA
Sterile water Normal saline 
 40
7) VAS scores after injection in study  and control groups  
MEAN VAS SCORES AT DIFFERENT TIMES  
PRIMIGRAVIDA  
Group  VAS at O 
Min. 
VAS at 10 
Min.  
VAS at 45 
Min. 
VAS at 90 
Min. 
     Group A                      
(Sterile water) 
7.62 + 0.645       
 
4.34+ 1.099 4.4 + 1.78 4.06+ 1.09 
     Group B 
(normal saline) 7.68 + 0.621        
 
5.74+ 1.818 7.4 + 8 7.6+ 0.25 
P value sterile 
water vs normal 
saline  
0.064 
Not 
significant 
0.043 
 Significant 
0.001 
Significant  
0.004 
Significant  
 
In study and control groups in primigravida, the VAS score before 
start of treatment was 7.62 in study group and 7.68 in control group, 
with statistical insignificance between the two groups( P=0.064). The 
mean  pain scores at 10min, 45min and 90min showed a statistically 
significant reduction in the sterile water group when compared to the 
normal saline group ( P<0.005). 
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MULTIGRAVIDA 
Group  VAS at O 
Min. 
VAS at 10 
Min.  
VAS at 45 
Min. 
VAS at 90 
Min. 
       Group A          
(Sterile water) 
7.6 + 0.68        
 
3.6+ 0.768 4.9 + 1.035 5.3+ 1.6 
Group B 
(normal saline) 
7.64 + 0.639        
 
4.34+ 0.895 6.8 +  0.729 7.4+ 1.82 
P value sterile 
water vs normal 
saline  
0.0652  (not 
significant) 
P<0.001 
(Significant) 
P< 0.001 
(Significant)  
P< 0.001 
(Significant) 
 
 In multigravida, the mean VAS score at the start of treatment was 
7.6 in Sterile water group and 7.64 in Normal saline group, with 
statistical insignificance between both groups ( P = 0.0652 ). The mean 
VAS pain score 10 minutes after treatment was found to be reduced in 
sterile water group, but not in normal saline group. Mean VAS pain 
scores at 45 and 90 minutes was also found to be reduced considerably 
in the sterile water group but not in the normal saline group ( P<0.001) 
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Duration of first stage of labour  
 Group A                      
(Sterile water) min 
Group B  
(normal saline) min 
Mean  SD Mean  SD 
PRIMIGRAVIDA  
331 58.04 360.3 30.28 
P value 
0.002 
MULTIGRAVIDA  
231.5  35.68 257 36.76 
P value 
0.001 
TOTAL 
281 308.5 
  
 P value 
                              0.003 
 
 
In primigravida, in study group the mean duration of first stage of 
labour was 331 minutes. In control group it was 360.3 minutes. P value 
was 0.002, and it was found to be statistically significant. 
In multigravida the mean duration of first stage of labour in study 
group was 231.5 minutes. In control group it was 257 minutes. P value 
was 0.001, and it was found to be statistically significant. 
Mean duration of first stage of labour in study group was 281 
minutes and in control group it was 308.5 minutes. P value was 0.003, 
the difference was statistically significant. 
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Duration of second  stage  
 Group A                      
(Sterile water) min 
Group B  
(normal saline) min 
Mean  SD Mean  SD 
PRIMIGRAVIDA  
32.71 7.98 33.98 6.77 
P value 
0.393 
MULTIGRAVIDA  
15.08 4.7 16.96 5.37 
P value 
0.065 
Total  
23.89 25.47 
 
         P = 0.0528 
  In study group, in primigravida the mean duration of second 
stage of labour was 32.71 minutes, whereas in control group it was 
33.98 minutes. In multigravida, the mean duration of second stage of 
labour was 15.08 minutes and in the control group it was 16.96 
minutes. 
Mean duration of second stage of labour was 23.89 minutes in study 
group and 25.47 minutes in control group. P value = 0.0528. it was 
statistically  not significant. There was no prolongation of second stage 
of labour in the study group. 
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Rate of Cervical dilatation (CM/hour)  
 Group A            
(Sterile water)                                           
CM/hr. 
Group B 
(normal saline)
CM /hr. 
Mean SD Mean SD 
PRIMIGRAVIDA  
1.556 0.363 1.578 0.293 
MULTIGRAVIDA  
2.206. 0.330 1.834 0.289 
  
P < 0.001 
The cervical dilatation at the time of administration of injection was 
2 cms – 3 cms  
 In study group, the mean cervical dilatation in the primigravida was 
1.55 ± 0.363cm/hr and in the multigravida it was 2 .2± 0.3cm/hr.  
In Control group, the mean cervical dilatation in the primigravida was 
1.5 ±0.29  cm/hr and in the multigravida it was 1.8 ±0.2cm/hr.  
Mean rate of cervical dilatation in study group was1.8cm/hr and it is 
1.5cm/hr in control group.  
There was a statistical significance between the two groups. 
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     Third  Stage Duration 
  Group A            
(Sterile water)    
(Min) 
Group B  
(normal saline) 
(Min) 
Primigravida 4.14 4.46 
Multigravida 3.56 3.4 
Mean  5.35 5.43 
SD 1.61 1.25 
     P = 0.569 
There was no statistical significance between both study and 
control groups in regard to the duration of third stage of labour. 
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APGAR Score 
 Apgar 1min Apgar 5 min 
Mean SD Mean SD 
Group A            
(Sterile water)   
7.9 1.43 8.5 0.6 
Group B  
(normal saline) 
 
7.8 1.25 8.4 0.8 
P 0.1576 0.7599 
 
There was no significant difference in the apgar scores of 
the two groups both at 1 minute and 5 minutes. 
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Average Data 
 1
st
 stage 
duration 
(min) 
Cervical 
dilatation 
(cms/hr) 
2
nd
 Stage 
Duration 
(min) 
3
rd
 Stage 
Duration 
(min) 
Total 
Duration 
(min) 
Apgar 
 
1’ 5’ 
Group A     
(Sterile 
water)                                           
281 1.75 23.5 5.3 309.8 7.9 8.5 
Group B  
(normal 
saline)  
 
308.5 1.6 25.4 5.4 339.3 7.8 8.4 
 
 The total duration of labour in study group was reduced (mean 
duration = 309.8 min) when compared to that of the control group 
(mean duration = 339.3 min). There was significant reduction in 
duration of first stage in the study group when compared to control 
group. There was no prolongation of labour in the second stage. There 
was no significant difference in Apgar scores of both groups. 
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Quality of pain relief 
Quality of 
pain relief 
Group A               
(Sterile water)                                          
Group B  
(normal saline)  
No. % No. % 
Excellent 30 30 0 0 
Moderate 34 34 13 13 
Mild 29 29 53 53 
Nil 7 7 34 34 
Total 100 100 
 
Among the patients in the study group, 93% had pain relief. Out 
of them 30% reported excellent pain relief and 34% reported 
moderate pain relief, 29% had mild pain relief and 7% reported no 
pain relief.  
Among the patients in the control group,13% of patients 
reported moderate pain relief,  mild pain relief was present in 53% of 
cases and 34% reported no pain relief. 
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Mode of delivery  
PRIMIGRAVIDA    
 Group A               
(Sterile water)                                          
Group B  
(normal saline)  
No. % No. % 
Labour 
Natural  
44 88 42 84 
Outlet 
forceps   
4 8 5 10 
LSCS 2 4 3 6 
Total  50 50 
 
MULTIGRAVIDA    
 Group A               
(Sterile water)                                          
Group B  
(normal saline)  
No. % No. % 
Labour 
Natural  
47 94 46 92 
Outlet 
forceps  
3 6 4 8 
LSCS Nil  Nil  
Total  50 50 
  
In the study group only 14% of  patients required assisted delivery 
and 6% of patients were delivered by LSCS. In the control group 18% of 
patients required assisted delivery and 8% of cases were delivered by 
LSCS.  
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Indications for assisted delivery:  
 Group A               
(Sterile water)                                           
Group B  
(normal saline)
 No. % No. % 
Failure of 
secondary forces  
1 14.28 2 22.22 
Prolonged second 
stage  
1 14.28 1 11.11 
Prophylactic 
Anemia, Severe 
PIH  
4 57.14 3 33.33 
fetal distress 1 14.28 3 33.33 
 
LSCS indication  
 Group A Group B 
Failure to 
progress 
1 1 
Fetal distress 1 2 
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DISCUSSION 
Sterile water injections for back pain in labour have been shown 
to be an effective method for relieving low back pain in labour in a 
number of studies. ( Peart
35,36
et al 2006; Reynolds
38
2002, Trolle
44
et al 
1959 ) 
Analgesic mechanism of action was provided by gate control or 
counter irritation theory.  
Interruption of pain pathway by injecting hypoosmolar 
solutions like sterile water produces analgesia which is not seen with 
normal saline since it is isoosmolar with blood.  
Our study compared two groups of patients, a sterile water group 
served as study group and a normal saline group served as control 
group. 
1. Maternal age 
In our study, the mean maternal age was 23.8 years in the sterile 
water group and 24.3 years in the normal saline group. In the study 
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conducted by Bahasadri
2
et al, Ader
1
 et al and Kushtagi
16 
et al, the 
mean age was 24.2 in the study group and 23.6 in the control group. 
2. Parity 
In our study 50% cases were primigravida 50% cases  were 
multigravida in both study and control groups. Similarly in studies by 
Laberque
17
 , Bahasadri
2
, Wiruchpongsanon
47
, Martensson
27
parity 
was equally distributed. 
3. Gestational age 
In our study all the patients were in the gestational age of 37-41 
weeks. Similarly in studies conducted by Vikkifogarty
45
et al, 
Bahasadri
2
, Wiruchpongsanon
47
, Martensson
27
et al, Ader
1
et al, 
Saxena
15
et al  included only term pregnancies. 
4. Membrane status  
In our study majority of the patients were from rural areas, 
regarding membrane status cases were equally distributed in both 
study and control groups. 
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In studies conducted by Bahasadri
2
et al, Ader
1
et al, 
Wiruchpongsanon
47
et al, Martensson
27
et al, Trolle
44
et al, 
Labrecque
17
et al cases in accordance with membrane status were 
equally distributed.
 
5. Median pain score – VAS score 
In our study VAS score before administration was statistically 
insignificant between both study and control groups P(0.064). 
similarly in studies conducted by Martensson et al, Trolle et al, 
Wirchpongsanon, Kushtagi et al, the VAS score before 
administration was statistically insignificant P(0.065). 
In our study among primigravida and multigravida after 
administration of injections mean pain reduction scores in the study 
and control groups were as follows: 
Cases Group A 
(Sterile water) 
Group B 
(Normal saline) 
P value 
Primigravida 
(n=100) 
Median pain  
score 
Base line – 7.6 
10 min – 4.34 
45 min – 4.4 
90 min – 4.06 
Median pain  
score 
Base line – 7.68 
10 min – 5.74 
45 min – 7.4 
90 min – 7.6 
 
 
0.064 
0.043 
0.001 
0.004 
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Multigravida 
(n=100) 
Median pain 
score 
Base line – 7.68 
10 min – 3.6 
45 min – 4.9 
90 min – 5.3 
Median pain  
score 
Base line – 7.6 
10 min – 4.34 
45 min – 6.8 
90 min – 7.4 
 
 
0.0652 
0.001 
0.001 
0.001 
 
In par with our study using the same Visual Analogue scale in 
the following studies the results are as follows: 
Studies Experimental Control  
Martennson 
and Wallin 
et al 
n=100 
Median pain 
score 
Base line – 7.6 
10 min – 2.3 
45 min – 2.5 
90 min – 6 
Median pain  
score 
Base line – 7.5 
10 min – 5.2 
45 min – 6.2 
90 min – 7.5 
Bahasadri et 
al 
n=100 
Median pain  
score 
Base line – 7.0 
10 min – 2.0 
45 min – 2.0 
90 min – 5.3 
Median pain  
score 
Base line – 7.6 
10 min – 4.34 
45 min – 4.8 
90 min – 7.4 
Kushtagi 
and Bhanu 
et al 
n=100 
Median pain 
score 
Base line – 8.0 
10 min – 5.0 
45 min – 4.0 
 
Median pain  
score 
Base line – 8.0 
10 min – 7.0 
45 min – 7.0 
 
 
All studies concluded mean pain score was significantly lower in 
sterile water group when compared to control group.other studies 
used numerical rating scale 100. 
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6. Route of administration and administration pain 
In our study we administered all injections intracutaneously, which 
produced sharp intense pain sensation that lasted for 30 seconds or 
more in sterile water group. The same injections can be administered 
subcutaneously without compromising analgesic effect. According to 
Martensson and Wallin et al studies mean pain reduction score was 
lower in both intracutaneous and subcutaneous group, but the pain of 
administration is less with subcutaneous group. 
Administration pain associated with the sterile water injections 
proved to be problematic. Despite providing significant reductions in 
pain levels, some women stated they were reluctant to repeat this 
treatment in future labours due to the transient sharp stinging 
sensation, Several researchers tried to modify administration 
technique. Martensson and Wallin argued that according to the 
concept of Diffuse noxious inhibitory control it was assumed that an 
intense stimulation, such as that obtained from intracutaneous sterile 
water injections, provided both osmotic stimulation from the salt-free 
water and distension of the firm cutaneous layers, was more effective 
than subcutaneous injections which merely induced osmotic 
stimulation.  
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7. Effect on FIRST stage of labour 
 In study group the mean duration of first stage of labour was 
281 minutes and in control group it was 308.5 minutes. (P 
value=0.003, statistically significant). There was statistically 
significant reduction in duration of first stage of labour. Trolle et al 
Danish study identified the analgesic effect of sterile water injection 
was not associated with any impairment of labour progress. As per 
Kasperink et al studies the pain reduction in the active stage of 
labour is associated with increased parasympathetic tone which 
improves labour, resulting in descent of the fetus and for correcting 
malrotation improving the likelihood of vaginal delivery. 
8. Rate of cervical dilatation 
In our study the mean cervical dilatation in the sterile water group 
in primigravida was 1.55 ± 0.36 cm/hr in multigravida it was 2.2 ± 
0.3 cm/hr. In normal saline group the mean cervical dilatation in 
primigravida was 1.5 ± 0.29 cm/hr and in multigravida it was 1.8 ± 
0.2 cm/hr. The mean cervical dilatation in study group was 1.8 cm/hr 
and in control group it was 1.5 cm/hr (P < 0.001) and was found to be 
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statistically significant. Similarly Hutton et al observed pain relief in 
first stage of labour had an impact on decrease in cervical tension 
thereby favoring dilatation of cervix. 
9. Effect on Second stage of labour 
 The mean duration of second stage of labour in sterile water 
group was 23.89 mts and in control group it was 25.47 mts (P = 
0.0528) not statistically significant. It had been observed that patients 
on sterile water injection experience less pain during second stage 
with out affecting the desire to push.  There is no undue prolongation 
of second stage. Trolle et al study suggest that the sterile water 
injection have an effect on the relaxation of pelvis and cervical 
tension. 
10. Duration of third stage of labour 
The third stage was actively managed in both groups. The mean 
duration of third stage of labour was 5.35 mts in the sterile water 
group and 5.43 mts in the control group (P = 0.569). The duration was 
not altered in both groups.  
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11.  Mode of Delivery 
 In our study, among primigravida, 88% were delivered by labour 
naturale with episiotomy, 8%were delivered by assisted delivery and 
4% were delivered by LSCS. 
Among multigravida, 94%were delivered  by labour naturale and 
6% by assisted delivery. 
 In control group among primigravida 84% were delivered by 
labour naturale, 10% by assisted delivery and 6% by LSCS. 
In control group among multigravida 92% were delivered by 
labour naturale, 8% by assisted delivery. 
Caesarean section was 2% in the study group and 3% the in control 
group. Similar to our study, the caesarean section rate was 4% in the 
study group and 6% in the control group by Kushtagi and Bhanu et 
al and in Vikki fogarty et al study the caesarean section rate was 
4.6% in sterile water group and 9.9%. 
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12. Effect on fetus: 
 The well being of the new born was unaltered in both groups as 
identified by identical APGAR Scores in both groups. 
 The mean apgar score at 1 minute in study group was 7.9 ± 0.6 
in control group it was 7.74 ± 0.676.  The mean apgar score at 5 
minutes  in study group was 8.02 ± 0.4 and in control group  it was 
8.27 ± 0.44. 
13. Effect on mother 
 Except for the initial deep stinging sensation lasting for 30 
seconds. There were no complications in the mother. They experience 
pain relief for a minimum of 90 minutes to upto 2 hrs post 
administration.  
14. Quality of pain relief 
In our study 93% of patients had pain relief out of them 30% of 
patients reported excellent pain relief and 34% of patients reported 
moderate pain relief and 29% of patients had mild pain relief, in 
control group only 53% of patients reported mild pain relief. In our 
study 85% of patients in the study group said that they will accept this 
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technique in their future labour similarly in Kasperink et al study 
69% in the sterile water group express their willingness to have the 
intervention again. 
Multigravida were better able to feel the difference and 
document the extent of pain relief and reported labour as much more 
satisfying. 
The validity of placebo could be argued with the administration 
of normal saline being less painful to administer but not completely 
painless, theoretically inducing some degree of analgesia. Bahasadri 
et al stated that women were not told how the different kinds of 
injections would be experienced during administration, thus they 
should be unable to judge, whether they had received active treatment 
or placebo. Accordingly, in our study, we found that the placebo 
group patients experienced only a mild pain relief which was not 
statistically significant as the sterile water group. 
 
 
 
Summary 
 62
SUMMARY 
 The study was performed on 200 antenatal mothers in active 
labour well matched in age, parity, gestational age, dilatation of 
cervix and membrane status.  
 The majority of patients belong to the age group of 21-25. In study 
group it was 58%, in control group it was 52%. The mean age of 
study group was 23.8 years. The mean age of control group was 
24.3 years.  
 70% of study cases were booked and 66% of control cases were 
booked. 
 Majority of the patients were from rural areas. 68% in study group 
and 64% in control group. 
 Primigravida and multigravida were equally distributed in the 
study (50%). 
 Median pain score of study and control groups were 
Cases Group A 
(Sterile water) 
Group B  
(Normal saline) 
P 
value 
Primigravida 
(n=100) 
Median pain 
score 
Base line – 7.6 
10 min     – 4.34 
45 min     – 4.4 
90 min     – 4.06 
Median pain 
score 
Base line – 7.68 
10 min     – 5.74 
45 min     – 7.4 
90 min     – 7.6 
 
 
0.064 
0.043 
0.001 
0.004 
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Multigravida 
(n=100) 
Median pain  
score 
Base line – 7.68 
10 min     – 3.6 
45 min     – 4.9 
90 min     – 5.3 
Median pain  
score 
Base line – 7.6 
10 min     – 4.34 
45 min     – 6.8 
90 min     – 7.4 
 
 
0.0652 
0.001 
0.001 
0.001 
 
Median pain score in the sterile water group was significantly 
lower than the placebo group at 10 mts, 45 mts, and 90 mts after 
injection (P < 0.001). 
 
 The duration of first stage of labour was significantly shorter in the 
study group denoting the favorable effect of sterile water injection 
on first stage of labour (P = 0.003). 
 There was no statistical difference in the duration of second stage 
of labour between study and control groups. The duration of 
second stage was not prolonged in the study group without 
affecting the ability of the patients desire to push  
(P = 0.0528). 
 The duration of third stage of labour was unaltered in both groups  
(P = 0.569).  
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 The neonatal outcome shown by APGAR scores were almost the 
same for both study and control groups. 
 In study group 91% of patients were delivered by labour naturale 
and in control group 88% of patients were delivered by labour 
naturale. 
 The assisted delivery rate was 7% in the study group and it was 9% 
in the control group 
 The major indication for assisted delivery in the study group and 
control group was prophylaxis since it included high risk cases. 
There was no undue prolongation of second stage in the study 
group. 
 The cesearean section rate was 2% in the study group and 3% in 
the control group.  
 Multigravida were better being able to feel the difference and 
reported labour to be more satisfying than primigravida, since they 
had previous labour experience. 
 93% of patients in study group reported pain relief, of them 30% of 
patients had excellent pain relief and 34% of patients moderate 
pain relief. 
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 There was no significant maternal or fetal side effects. 
 The only adverse effect is a sharp, brief bee sting like pain 
sensation lasting for a maximum of 30 seconds. 
 Placebo treated group had mild analgesic effect, but it was not 
statistically significant as the sterile water group. 
 In the post partum follow up, 85% of patients reported that they 
will accept this technique in their future labour for pain relief.  
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Summary of proven benefits of sterile water injections 
Sterile water injections: 
1.  Provide rapid and effective low back pain relief during labour. 
2.  Have no apparent side effects 
3.  Offers simplicity of use and a high level of success. 
4.  Are non-pharmacological 
5.  Decrease the need for epidural anaesthesia 
6.  Delay the use of epidural anaesthesia 
7.  Have no effect on a mothers state of consciousness 
8.  Can be repeated 
9.  Don’t limit a mothers ability to move about 
10. May be used while waiting for a anaesthetist 
11. Do not interfere in labour progress or ability to push 
12. Have application for use in rural/remote areas and developing  
      Countries 
13. Have a role to play with their analgesic effect on pelvic floor  
   Tone, cervical tension and fetal rotation. 
14. Can be administered by a nurse or midwife. 
Conclusion 
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CONCLUSION 
 
  Sterile water injections induce a statistically significant, 
dramatic analgesic effect on the low back pain experienced by 
women during labour lasting from a minimum of 10 minutes to 90 
minutes and a maximum of 2 hours post administration.  
  It has a favorable impact on the progress of labour. It 
augments cervical dilatation and shortens the first stage of labour. 
Duration of second stage of labour is not affected. There is 
absolutely no untoward effect on mother and fetus. 
  To Conclude, Sterile water injections represent an 
important safe, cost effective, drug free option that should be 
made available to all woman experiencing unrelenting back pain 
during child birth. 
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PROFORMA 
Name:                 Age:  
IP No.            LMP:  
Unit :                                                                              EDD:  
Booked / Unbooked:  
Date and time of admission:    Obstetric Table:   
Complaints  
Past History :        
 Medical:  
 Surgical:  
Menstrual History :  
Marital history :  
Personal History :  
Obstetric History :  
General Examination :  
Level of consciousness    Pulse  
          CVS        Blood pressure  
RS        Temperature  
Back and Spine      Height   Weight  
Per Abdominal Examination:   
Per Vaginal Examination:  
Bishop’s score: 
Investigation :  
USG abdomen  
Group A  
 Intracutaneous Injection of Sterile water  
Group B  
          Intracutaneous Injection of Normal Saline  
Number of Injections 1         2          3         4  
VISUAL ANALOGUE SCORE  @ Time of Injection  
0 min   10 mts    45mts    
 90 mts                 2 hrs  
          
 No pain ( 0 ) 
Slight pain ( 1-3 )  
Moderate pain ( 4-6 )    
Severe pain ( 7- 10 )  
Duration of first stage of labour  
Rate of cervical dilatation 
Duration of second stage of labour.  
Duration of third stage of labour.  
Date and Time of Delivery:     
Mode of delivery: 
Sex        Birth weight.  
APGAR    1 min   5 min 
Will she accept this technique in her future labour  
                          Yes          No  
 Patients Satisfaction with sterile water injection 
 
Very satisfied   `  Satisfied 
Dissatisfied     Very dissatisfied 
 
 
 
 
Partogram 
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1 32304 19 primi nil 7 6 6 7 1.4 4h 15m 40 10 LN - epi moderate 2.8 8 8
2 32378 22 primi nil 8 3 4 4 1.2 6h 15m 30 6 LN - epi excellent 2.5 8 8
3 32767 20 primi nil 7 4 5 6 1.1 6h 30m 35 7 LN - epi moderate 2.4 8 8
4 32766 18 primi nil 8 7 6 6 1.4 5h 00m 40 6 LN - epi mild 2.7 8 9
5 30238 21 primi nil 9 3 3 4 1.3 5h 45m 45 7 LN - epi excellent 2.7 8 8
6 31980 24 primi nil 8 5 6 6 1.2 6h 30 7 LN - epi moderate 2.9 8 7
7 30616 25 primi PIH 7 6 6 6 1 6h 40m 45 5 LN - epi mild 2.8 8 8
8 36070 19 primi PROM 7 5 5 6 1.2 6h 35 4 LN - epi mild 3.5 8 8
9 36112 19 primi nil 8 5 5 6 1.4 6h 30m 50 6 LN - epi moderate 2.8 8 7
10 34761 24 primi nil 9 3 4 4 1.1 6h 20m 40 7 LN - epi excellent 2.7 8 8
11 37770 20 primi nil 7 5 5 6 1.2 5h 40m 35 6 LN - epi mild 2.7 8 8
12 36807 21 primi nil 8 5 5 6 1.3 7h 35 5 LN - epi moderate 3.2 8 8
13 37213 25 primi nil 7 6 7 7 1.1 7h 10m 50 5 LN - epi mild 2.8 8 8
14 38328 20 primi Sev. PIH 7 7 6 6 2 5h 30m 30 8 outlet prophy mild 2.5 7 8
15 37001 20 primi nil 7 3 4 5 1.4 6h 30m 30 7 LN - epi excellent 2.5 8 9
16 39484 26 primi PROM 7 3 4 6 1.8 6h 20m 40 8 LN - epi excellent 2.8 8 9
17 36711 23 primi nil 7 3 6 6 1.1 7h 45 6 LN - epi moderate 2.8 8 8
18 40301 24 primi mild PIH 8 4 5 6 2 5h 30 8 LN - epi moderate 2.5 8 10
19 38872 28 primi hypothy 8 4 5 6 1.5 6h 15m 35 10 LN - epi moderate 2.6 7 8
20 41001 20 primi PROM 8 4 5 7 1.4 6h 30m 45 7 LN - epi mild 3.3 7 8
21 40989 22 primi nil 8 5 7 7 1.2 7h 40 6 LN - epi mild 3.25 8 8
22 38983 20 primi nil LSCS mild 3 7 8
23 42884 20 primi PIH 7 4 6 7 1.8 4h 40m 30 6 LN - epi mild 1.8 7 8
24 41631 24 primi nil 8 4 6 7 1.8 3h 30m 40 LN - epi mild 2.8 8 9
25 48507 22 primi nil 8 6 6 7 1.7 5h30m 25 5 LN - epi moderate 2.5 8 8
VAS SCORE
26 51879 21 primi PROM 7 6 6 7 1.4 5h 15m 25 8 outlet/ fail of sec moderate 2.6 7 8
27 52454 20 primi Rh neg 8 3 4 4 1.2 6h 15m 30 6 LN - epi excellent 3.3 8 8
28 42972 22 primi nil 7 4 6 6 1.8 4h 40m 25 7 outlet/ fet distrs mild 3.1 7 8
29 41441 24 primi nil 8 4 5 6 1.6 5h 20 6 LN - epi moderate 2.25 8 9
30 42076 20 primi nil 8 5 6 6 2 4h 30m 20 5 LN - epi moderate 2.8 8 8
31 38092 26 primi nil 7 3 3 4 2.1 4h 25 7 LN - epi excellent 2.7 8 8
32 48391 25 primi nil 7 5 5 6 LSCS PROM FD 3.2 8 9
33 42992 23 primi PROM 8 4 6 6 1.7 5h 15m 25 5 LN - epi moderate 3 8 8
34 38455 24 primi nil 7 3 4 4 2 4h 15m 25 6 LN - epi mild 2.5 7 8
35 38447 21 primi long infertility 7 4 4 6 1.7 5h 30 5 LN - epi excellent 2.5 8 8
36 38419 21 primi nil 7 4 7 7 1.6 5h 40m 35 5 LN - epi nil 2.8 8 8
37 38929 24 primi nil 7 4 5 5 1.4 6h 20m 30 5 LN - epi mild 2.7 7 8
38 34050 26 primi nil 7 4 8 8 1.2 7h 40 8 LN - epi nil 2.25 8 9
39 38323 20 primi anemia 8 4 5 6 1.6 5h 30 7 LN - epi moderate 3 8 9
40 38324 22 primi nil 8 3 4 4 1.4 5h 20m 20 5 LN - epi excellent 2.6 8 8
41 38923 24 primi nil 8 3 4 5 1.8 5h 25 6 LN - epi excellent 2.3 8 9
42 38901 19 primi PIH 8 3 6 6 2 4h 30 5 LN - epi moderate 2.8 7 8
43 38912 22 primi nil 8 4 5 6 2.2 4h 15m 35 5 LN - epi moderate 2.9 7 8
44 38959 24 primi nil 8 4 5 6 2.1 4h 30 6 LN - epi moderate 3 8 9
45 38419 21 primi PROM 8 4 5 7 1.8 4h 40 8 LN - epi mild 3.1 8 8
46 32177 25 primi nil 8 5 7 7 2.2 4h 15m 25 5 LN - epi mild 2.7 8 8
47 31162 23 primi nil 8 5 6 7 1.6 5h 40m 30 5 LN - epi mild 3.2 7 8
48 20822 22 primi nil 8 4 6 7 1.4 6h 35 6 outlet/failure of sec mild 3.5 6 8
49 24139 24 primi nil 8 4 6 7 1.2 6h 35 7 LN - epi mild 2.8 7 8
50 24062 25 primi PROM 9 6 9 9 2.5 3h 30m 15 2 LN - epi nil 2.7 7 8
51 32421 29 G2P1L1 NIL 8 4 5 5 2.3 4h 15m 20 5 LN - epi excellent 3 8 9
52 32942 28 G4P1L1A2 NIL 8 4 6 7 2.2 4h 20m 15 4 LN - epi mild 2.75 7 8
53 36088 29 G2P1L1 NIL 8 3 4 4 2 3h 30m 12 3 LN - epi excellent 2.5 7 8
54 36058 21 G2P1L1 PIH 9 4 6 6 2.6 3h 40m 10 2 LN - epi mild 2.8 8 9
55 38074 25 G2P1L1 NIL 7 4 5 5 2.1 4h 15m 15 5 LN - epi moderate 2.25 8 8
56 37989 26 G2P1L1 RH NEG 7 4 6 6 2.2 4h 15m 12 4 LN - epi moderate 2.9 8 8
57 38325 22 G2P1L1 NIL 8 4 4 4 2.1 3h 10 6 LN - epi moderate 2.5 8 9
58 33984 24 G2P1L1 PROM 7 4 5 6 1.8 5h 20m 25 7 LN - epi excellent 2.8 8 9
59 36781 28 G2P1L1 NIL 7 4 6 5 2.5 3h 30 5 LN - epi mild 2.9 7 8
60 39309 28 G2P1L1 NIL 8 4 6 7 2 3h 15 3 LN - epi nil 3.1 8 9
61 39729 22 G2P1L1 NIL 8 3 4 7 2.5 3h 30m 20 2 LN - epi excellent 3 8 9
62 39102 21 G2P1L1 ANEMIA 8 4 6 4 1.8 3h 15m 15 4 outlet prophy mild 3.25 7 8
63 40967 23 G3P2L2 PIH 8 4 4 4 1.9 5h 20 4 outlet prophy excellent 2.8 7 8
64 42935 25 G2P1L1 NIL 7 4 4 4 2.5 3h 30m 20 3 LN - epi excellent 2.8 7 8
65 42990 22 G2P1L1 NIL 7 4 5 6 2 3h 40m 10 5 LN - epi moderate 2.7 8 9
66 42972 24 G2P1L1 NIL 8 3 4 4 1.5 4h 15m 10 6 LN - epi excellent 3.2 7 8
67 44219 26 G2P1L1 NIL 7 4 7 7 2.6 3h 15m 15 4 LN - epi mild 3.5 8 8
68 42731 21 G2P1L1 NIL 7 4 5 6 2.5 3h 15m 20 3 LN - epi moderate 2.7 8 9
69 47986 25 G2P1L1 NIL 7 3 4 4 1.8 4h 15 5 LN - epi excellent 2.8 7 8
70 45166 28 G3P1L1A1 NIL 8 4 5 6 2.1 4h 15m 10 4 LN - epi moderate 3 7 8
71 48193 26 G3P2L2 PIH 8 3 3 4 2.1 4h 10 6 LN - epi excellent 2.8 8 9
72 48187 23 G2P1L1 PROM 9 3 6 7 1.8 3h 20 5 LN - epi mild 2.6 8 9
73 48387 26 G2P1L1 NIL 7 3 4 4 1.4 3h 40m 15 5 LN - epi excellent 2.7 8 9
74 48484 25 G2P1L1 NIL 7 4 6 6 1.6 5h 15m 15 4 LN - epi moderate 3.2 7 7
75 48325 21 G2P1L1 NIL 7 7 8 7 1.8 3h 30m 10 3 LN - epi nil 3.5 8 9
76 48815 28 G2P1L1 NIL 8 3 4 4 1.5 3h 30m 10 4 LN - epi excellent 4 8 9
77 48930 27 G2P1L1 NIL 8 4 5 6 2.2 3h 45m 10 5 LN - epi moderate 2.5 7 8
78 48938 24 G2P1L1 NIL 9 4 6 7 2.4 4h 50m 15 6 LN - epi mild 2.7 8 9
79 40995 28 G2P1L1 NIL 7 4 5 5 1.9 4h 15m 20 3 LN - epi moderate 2.8 7 8
80 41243 30 G2P1L1 NIL 7 4 5 5 2 4h 15 4 LN - epi excellent 2 7 8
81 42148 26 G2P1L1 NIL 8 3 4 4 2.1 3h 40m 15 4 LN - epi excellent 2.1 7 8
82 43747 25 G2P1L0 BOH 7 4 6 6 1.8 3h 30m 18 5 LN - epi moderate 3 7 8
83 42163 24 G2P1L1 NIL 7 3 5 5 1.5 3h 40m 10 4 LN - epi moderate 2.3 8 9
84 42659 26 G2P1L1 NIL 7 3 6 7 1.6 3h 35m 15 4 LN - epi mild 2.5 8 9
85 42440 23 G2P1L1 NIL 8 3 4 4 1.7 4h 20 5 LN - epi excellent 2.4 8 9
86 42464 20 G2P1L1 NIL 8 3 4 4 1.8 4h 15m 15 6 LN - epi moderate 3.3 8 8
87 42134 30 G2P1L1 NIL 7 3 3 4 1.7 3h 30m 10 4 LN - epi excellent 2.8 7 8
88 45018 32 G3P2L2 NIL 7 4 5 6 2.4 3h 40m 12 4 LN - epi moderate 2.7 7 8
89 44430 25 G2P1L1 ANEMIA 8 4 5 5 2 4h 20 4 outlet prophy moderate 3 7 8
90 42304 32 G2P1L1 PROM 8 3 4 4 1.8 3h 15 6 LN - epi excellent 3 8 9
91 42518 29 G2P1L1 NIL 7 4 5 6 1.6 3h 40m 10 5 LN - epi mild 2.5 7 8
92 40401 21 G2P1L1 NIL 7 3 4 4 2 3h 15 8 LN - epi excellent 1.8 7 8
93 43857 25 G2P1L1 NIL 8 3 4 4 2.1 4h 10m 10 4 LN - epi excellent 3.5 7 8
94 40984 24 G2P1L1 NIL 8 4 6 7 1.6 4h 15m 20 3 LN - epi mild 3.25 7 8
95 40719 25 G2P1L1 PROM 9 4 5 5 2.4 3h 25 4 LN - epi moderate 3.1 7 8
96 41683 21 G2P1L1 NIL 8 3 4 4 2.6 4h 15 8 LN - epi excellent 2.8 8 9
97 43973 28 G2P1L1 NIL 7 3 4 4 1.8 4h 15m 10 6 LN - epi excellent 2.6 7 8
98 42114 26 G2P1L1 NIL 7 6 6 7 1.9 4h 10m 15 5 LN - epi nil 2.6 7 8
99 43141 25 G2P1L1 PROM 7 3 4 7 2.4 5h 10 4 LN - epi moderate 2.5 7 8
100 42446 24 G2P1L1 NIL 8 3 4 6 1.8 4h 20m 15 3 LN - epi moderate 2.4 7 8
101 419055 28 PRIMI NIL 7 5 6 6 2.4 4h 30 6 outlet/fail of sec moderate 3.5 6 9
102 41596 29 PRIMI NIL 8 6 7 8 2.5 4h 15m 25 4 LN - epi mild 1.8 7 8
103 41923 21 PRIMI NIL 7 5 7 8 1.6 7h 40 8 LN - epi mild 2.6 8 9
104 41933 21 PRIMI NIL 8 4 7 7 2 5h 30 5 LN - epi mild 3.25 7 8
105 41951 21 PRIMI NIL 9 5 7 8 2.1 6h 25 8 LN - epi nil 2.8 7 9
106 41976 19 PRIMI NIL 8 6 7 8 1.8 6h 15m 30 4 LN - epi mild 2.7 7 8
107 41979 18 PRIMI PIH 7 5 7 7 1.5 5h 30m 40 8 LN - epi mild 3.2 8 9
108 42379 25 PRIMI EPILEPSY 7 4 8 9 1.3 7h 45 4 LN - epi moderate 2.9 7 8
109 42374 23 PRIMI NIL 8 5 8 8 1.2 6h 30m 30 5 LN - epi nil 3.2 8 8
110 43748 19 PRIMI NIL 9 6 8 8 1.6 6h 20m 35 6 LN - epi nil 3.25 7 8
111 42143 24 PRIMI NIL 7 6 7 7 1.8 6h 20m 25 6 LN - epi mild 2.25 7 9
112 43060 23 PRIMI NIL 8 5 7 7 1.5 5h 40m 40 4 LN - epi nil 2.5 8 9
113 42850 21 PRIMI PROM 7 5 7 8 1.3 6h 30m 30 4 outlet/fetal distress nil 3.2 6 8
114 44156 20 PRIMI PROM 7 4 LSCS nil 2.6 7 8
115 44112 26 PRIMI NIL 7 5 8 9 2 5h 25 6 LN - epi moderate 2.9 8 8
116 45275 27 PRIMI NIL 7 4 8 7 1.8 5h 15m 40 5 LN - epi mild 3 7 8
117 45264 19 PRIMI NIL 7 4 7 7 1.6 6h 35 8 LN - epi nil 3.2 8 9
118 42232 20 PRIMI PROM 8 4 7 7 1.5 6h 15m 45 4 LN - epi nil 26 8 9
119 42345 29 PRIMI NIL 8 4 8 9 1.4 6h 20m 45 6 LN - epi mild 2.8 7 8
120 44595 22 PRIMI NIL 8 6 7 8 2 5h 30m 30 6 LN - epi mild 3.25 8 9
121 44102 26 PRIMI NIL 8 4 8 8 1.6 6h 15m 35 5 LN - epi mild 2.75 7 8
122 41902 21 PRIMI NIL 9 7 8 7 1.5 6h 15m 25 5 LN - epi mild 2.4 6 8
123 42077 20 PRIMI NIL 7 5 7 8 1.4 6h 15m 30 5 LN - epi mild 2.75 6 8
124 42076 23 PRIMI PIH 8 4 7 7 1.5 6h 30m 35 6 LN - epi mild 3 6 8
125 42285 21 PRIMI PROM 8 4 8 9 1.5 5h 45 8 outlet/fetal distress nil 3.2 7 9
126 42415 20 PRIMI NIL 7 4 7 7 1.4 5h 50m 40 8 LN - epi mild 2.6 7 8
127 42411 22 PRIMI NIL 8 4 8 8 1.3 5h 40m 30 8 LN - epi mild 2.9 8 9
128 42230 23 PRIMI NIL 7 4 8 9 LSCS 2.7 8 9
129 44065 26 PRIMI NIL 8 4 8 8 1.5 6h 30m 35 6 LN - epi moderate 1.8 8 8
130 42232 25 PRIMI NIL 8 6 8 9 1.3 6h 20m 25 5 LN - epi nil 2.4 8 8
131 40651 24 PRIMI NIL 7 5 7 7 1.2 6h 15m 40 8 LN - epi mild 1.9 7 8
132 40500 25 PRIMI PROM 7 6 7 8 1.4 5h 50m 45 4 LN - epi mild 2.5 7 8
133 42632 21 PRIMI NIL 8 4 7 8 1.3 6h 30m 30 5 outlet/fail of sec mild 3.7 7 8
134 42644 PRIMI NIL 7 5 7 8 1.2 6h 15m 30 5 LN - epi mild 3.1 7 8
135 43084 26 PRIMI NIL 7 6 7 7 1.4 6h 40 8 LN - epi mild 2.5 8 9
136 42825 26 PRIMI NIL 7 4 7 7 1.8 6h 15m 30 6 LN - epi nil 2.6 7 8
137 42804 23 PRIMI NIL 7 4 6 8 1.5 6h 40m 35 5 LN - epi mild 3.6 6 8
138 43005 20 PRIMI ANEMIA 7 6 7 7 1.3 6h 15m 40 8 outlet/prophy nil 2.4 7 8
139 42855 24 PRIMI PIH 8 4 7 7 2 5h 40m 30 4 LN - epi nil 3 6 9
140 42922 21 PRIMI PROM 8 5 6 8 LSCS mild 2.5 7 8
141 43120 21 PRIMI NIL 8 5 7 7 1.6 6h 25 6 LN - epi nil 2.8 7 8
142 42058 30 PRIMI NIL 8 5 7 7 1.8 4h 40m 40 5 LN - epi nil 3.2 6 8
143 43253 25 PRIMI NIL 8 4 6 7 1.3 5h 50m 50 6 LN - epi mild 2.25 7 9
144 43242 21 PRIMI NIL 8 4 7 9 1.4 5h 30m 40 8 LN - epi mild 2.6 7 8
145 42854 25 PRIMI NIL 8 5 7 8 1.4 5h 50m 30 8 LN - epi mild 2.4 8 9
146 43740 21 PRIMI NIL 8 4 8 9 1.6 6h 25 8 LN - epi mild 2.5 7 8
147 45520 24 PRIMI PROM 8 4 8 8 1.5 6h 25 7 LN - epi mild 2.6 7 9
148 42003 22 PRIMI PIH 8 4 7 8 1.8 5h 15m 30 7 LN - epi mild 1.8 6 9
149 42064 21 PRIMI PROM 8 4 8 8 1.6 5h 40m 30 9 LN - epi mild 2.5 7 8
150 41735 24 PRIMI NIL 9 5 7 8 1.5 6h 35 6 LN - epi mild 2.4 8 9
151 49352 28 G2P1L1 NIL 8 4 7 8 2 4h 15m 25 4 LN - epi moderate 2.7 7 9
152 41752 24 G2P1L1 NIL 8 5 7 8 1.5 4h 30m 30 5 LN - epi mild 2.5 8 9
153 41746 21 G2P1L1 PROM 8 5 8 8 2.3 3h 40m 18 2 LN - epi mild 3.3 7 8
154 41963 24 G2P1L1 NIL 9 6 7 8 8 4h 40m 20 4 LN - epi mild 2.5 7 8
155 41962 24 G2P1L1 NIL 7 6 7 8 1.5 4h 15m 15 6 LN - epi mild 2.8 8 9
156 41749 28 G2P1L1 PIH 7 5 7 8 1.2 5h 25 5 LN - epi mild 1.9 7 9
157 41796 27 G2P1L1 ANEMIA 8 5 6 8 2 4h 30m 20 4 LN - epi nil 3.5 8 9
158 41527 28 G3P2L2 PROM 7 5 7 8 2.4 3h 40m 10 3 LN - epi nil 3.25 8 9
159 42369 29 G3P1L1A1 NIL 7 5 7 7 2.3 3h 30m 15 5 LN - epi nil 2.2 7 8
160 42476 30 G2P1L1 NIL 8 5 8 8 2.2 5h 25 5 LN - epi nil 2.4 7 8
161 42126 25 G2P1L1 NIL 8 4 6 8 1.8 4h 15m 15 2 LN - epi mild 2.3 8 9
162 44109 26 G2P1L1 NIL 8 4 7 8 2 4h 30m 10 4 LN - epi nil 2.4 8 9
163 45258 25 G2P1L1 NIL 8 3 7 7 1.6 4h 12 5 LN - epi mild 2.2 7 9
164 42602 24 G2P1L1 NIL 7 3 7 8 1.6 3h 40m 18 6 LN - epi mild 3.3 7 8
165 40307 21 G2P1L1 NIL 7 4 7 8 2 3h 20 15 2 LN - epi mild 3 6 8
166 43898 21 G2P1L1 NIL 8 4 6 8 8 5h 15 4 LN - epi moderate 2.6 7 9
167 43954 25 G2P1L1 PIH 7 4 7 8 1.5 5h 20 4 outlet prophy moderate 2.3 7 8
168 41354 28 G2P1L1 NIL 7 3 6 7 2.1 4h 40m 10 5 LN - epi moderate 1.8 8 9
169 43989 27 G2P1L1 NIL 7 3 7 8 2.2 4h 30m 10 5 LN - epi mild 2.3 7 8
170 42162 29 G2P1L1 NIL 8 4 6 8 1.8 4h 40m 15 6 LN - epi mild 2.4 7 8
171 42410 28 G2P1L0 NIL 8 4 7 8 1.5 4h 15m 18 6 LN - epi mild 2.7 8 9
172 42525 28 G3P2L1 NIL 9 4 6 8 1.9 3h 40m 20 4 LN - epi mild 3 8 9
173 42082 28 G3P1L1A1 PROM 7 5 5 8 2 3h 20m 25 2 LN - epi nil 3.2 8 9
174 44084 30 G3P2L2 NIL 7 4 5 8 1.4 4h 40m 25 5 LN - epi mild 3.1 7 8
175 44066 25 G2P1L1 NIL 7 5 5 8 1.6 4h 15m 15 2 LN - epi mild 2.8 7 8
176 42080 24 G2P1L1 PROM 8 4 5 8 1.6 5h 10 4 LN - epi mild 2.7 7 8
177 40840 28 G2P1L1 NIL 8 4 5 8 1.8 4h 30m 12 5 LN - epi moderate 2.6 6 8
178 40642 28 G2P1L1 NIL 9 5 5 8 2 3h 40m 18 6 LN - epi mild 2.5 6 8
179 45161 27 G2P1L1 NIL 7 6 6 8 2.1 3h 30m 15 2 LN - epi nil 3 7 8
180 43089 26 G2P1L1 NIL 7 6 6 8 2.2 5h 15 4 outlet/fetal distress nil 3.25 7 8
181 45381 28 G2P1L1 NIL 8 5 6 8 2 4h 15m 20 4 LN - epi mild 2.5 8 9
182 49479 29 G2P1L1 PIH 7 4 5 8 2.1 4h 30m 10 5 LN - epi moderate 2.8 8 9
183 45546 27 G2P1L1 PROM 7 3 5 8 1.4 4h 10 5 LN - epi moderate 2.5 8 9
184 43245 26 G2P1L1 NIL 7 5 6 8 1.5 3h 40m 15 6 LN - epi mild 2.6 7 9
185 45491 21 G2P1L1 NIL 8 4 6 8 1.6 3h 20 18 6 LN - epi nil 2.5 7 9
186 45848 24 G2P1L1 NIL 8 3 6 8 1.7 6h 20 5 LN - epi nil 3.5 7 8
187 43128 22 G2P1L1 NIL 7 4 6 8 1.8 5h 15 5 LN - epi nil 3.8 7 8
188 42878 21 G2P1L1 NIL 7 3 6 8 2 4h 40m 20 4 LN - epi nil 3 7 8
189 43233 24 G2P1L1 NIL 8 4 7 8 1.4 4h 30m 25 5 LN - epi nil 2.6 8 9
190 43252 25 G2P1L1 PROM 8 6 7 8 1.8 4h 40m 30 6 outlet/fail of sec nil 1.8 8 8
191 43091 28 G2P1L1 NIL 7 5 7 7 2 3h 30m 10 6 LN - epi nil 2.5 8 9
192 43035 27 G3P2L2 NIL 7 4 5 8 1.6 4h 20m 15 4 LN - epi moderate 2.3 8 9
193 43092 27 G2P1L1 ANEMIA 8 4 5 8 2.2 4h 20 3 outlet/prophy moderate 2.2 6 8
194 49036 29 G2P1L1 NIL 8 6 6 8 2.2 4h 20 4 LN - epi mild 2.1 8 8
195 41915 28 G2P1L1 NIL 9 4 5 8 1.8 3h 40m 10 5 LN - epi mild 1.8 8 9
196 42071 27 G3P2L2 NIL 8 4 6 8 1.7 3h 30m 12 3 LN - epi mild 2.25 8 9
197 42296 24 G2P1L1 PROM 7 4 7 8 1.8 4h 20m 15 2 LN - epi nil 3 8 9
198 41765 21 G2P1L1 NIL 7 4 5 8 2 4h 30m 15 5 LN - epi nil 2.5 6 8
199 41828 21 G2P1L1 NIL 7 4 5 8 2.1 4h 15m 12 5 LN - epi nil 2.4 8 8
200 45268 24 G2P1L1 NIL 8 3 6 8 1.4 4h 20m 20 6 LN - epi mild 2.3 8 8
